Cayman’s PAD1 Inhibitor Screening Assay Kit (Ammonia) provides a convenient method for screening human PAD1 inhibitors. PAD1 deiminates N-α-benzoyl-L-arginine ethyl ester (BAEE)

PAD1 Inhibitor Screening Assay Kit (Ammonia) – 96 wells

Brand:
Cayman
Storage:
-80

Cayman’s PAD1 Inhibitor Screening Assay Kit (Ammonia) provides a convenient method for screening human PAD1 inhibitors. PAD1 deiminates N-α-benzoyl-L-arginine ethyl ester (BAEE), a non-natural substrate with similar kinetic properties to the natural substrates, producing ammonia.{18133} Ammonia reacts with a detector resulting in a fluorescent product. Fluorescence is then analyzed with an excitation wavelength of 405-415 nm and an emission wavelength of 470-480 nm.  

 

Available on backorder

Add to quotes
SKU: 701450 - 96 wells Category:

Description

Cayman’s PAD1 Inhibitor Screening Assay Kit (Ammonia) provides a convenient method for screening human PAD1 inhibitors. PAD1 deiminates N-α-benzoyl-L-arginine ethyl ester (BAEE), a non-natural substrate with similar kinetic properties to the natural substrates, producing ammonia. Ammonia reacts with a detector resulting in a fluorescent product. Fluorescence is then analyzed with an excitation wavelength of 405-415 nm and an emission wavelength of 470-480 nm.

Formulation:

Formal name:

Synonyms:  PADI1|PDI1|Peptidylarginine Deiminase 1|Protein Arginine Deiminase 1

Host:

Imunogen:

Applications: 

Clone:

Purity:

Origin:

Application|High-Throughput Screening||Product Type|Assay Kits|Fluorometric Assays||Product Type|Assay Kits|Inhibitor Screening Assays||Research Area|Epigenetics, Transcription, & Translation|Writers|Citrullination

Related products